SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Release:

Cedars-Sinai Medical Center Begins Certification to Implant SynCardia's Total Artificial Heart

Los Angeles Hospital #1 in U.S. Heart Transplant Volume for 2010

Jaime Moriguchi, MD, medical director of the Mechanical Circulatory Support Program, Cedars-Sinai Medical Center Jaime Moriguchi, MD, medical director of the Mechanical Circulatory Support Program, Cedars-Sinai Medical Center TUCSON, Ariz. – March 24, 2011 – SynCardia Systems, Inc. announced today that the 13-member multi-disciplinary team from Cedars-Sinai Heart Institute will become the first in Los Angeles to complete certification to implant the SynCardia temporary Total Artificial Heart. During 2010, Cedars-Sinai performed the most heart transplants, 75, of all the 116 U.S. medical centers that performed adult heart transplants.

"We are excited to offer the Total Artificial Heart as a bridge to transplant for patients suffering from end-stage, biventricular heart failure who have exhausted all other treatment options," said Jaime Moriguchi, MD, medical director of the Mechanical Circulatory Support Program. "Similar to a heart transplant, the Total Artificial Heart is the only device that eliminates the symptoms and source of biventricular failure by replacing both ventricles and the four valves."

Said Fardad Esmailian, MD, surgical director for the Heart Transplant and Ventricular Assist Device Program, "Cedars-Sinai patients with advanced heart failure could begin receiving the Total Artificial Heart as early as next week."

SynCardia is currently conducting an FDA-approved Investigational Device Exemption (IDE) clinical study of the Freedom® driver, the first U.S. portable driver designed to power SynCardia's Total Artificial Heart both inside and outside the hospital. Weighing 13.5 lbs, the wearable Freedom driver is designed to allow stable Total Artificial Heart patients who meet study criteria to live at home and in their community while they wait for a matching donor heart.  

U.S. News & World Report ranked Cedars-Sinai among the top 15 hospitals for Heart and Heart Surgery for 2010-2011. Since its establishment in 1988, the Heart Transplant Program at Cedars-Sinai has performed more than 650 heart transplants.

To become a SynCardia Certified Center, hospitals must apply for and complete a rigorous four-phase certification process, including the first implant proctored by an experienced Total Artificial Heart surgeon. Currently, there are 37 SynCardia Certified Centers around the world including 15 in the U.S. There are an additional 12 U.S. centers and 18 international hospitals currently completing the certification process.


About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the temporary Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

SynCardia Contact:
Janelle Drumwright,, (520) 547-7463

Search offcanvas